Google
GALDY 株価分析 — GALDERMA GROUP AG (Healthcare >> Drug Manufacturers - Specialty & Generic)
GALDY に関するよくある質問
GALDYのROE（自己資本利益率）は？
GALDERMA GROUP AGのROEは7.52%です。
GALDYの配当利回りは？
GALDERMA GROUP AGの配当利回りは0.20%です。
GALDYの品質スコア（Quality Score）は？
当社のAIはGALDYの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
GALDYは今が買い時ですか？
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
GALDYはどのセクターに属しますか？
GALDERMA GROUP AGはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NYSE市場）
GALDY AI Analysis Summary
Our AI summary for GALDY: GALDERMA GROUP AG (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of 7.52%, a dividend yield of 0.20%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 43.60
Price
-1.50
(-3.33%)
Day Change
|
|
|---|
GALDY, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 43.60 |
| PBV / Sector |
1.26 / 3.22
GOOD
|
| Earning Per Share | 2.61 |
| PE / Sector |
N/A / 29.79
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
0.49 M
GREAT
|
| Average 1W Daily Value |
0.35 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
52% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:53 |
| Symbol | GALDY |
| Name | GALDERMA GROUP AG |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 1,165.94 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 10,227.20 / 10,754.62 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Zählerweg 10, Zug, Switzerland, 6300
Phone: 41 58 455 85 92
Website: https://www.galderma.com
Employees: 7,676
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
